Penta‐O‐galloyl‐β‐D‐glucose ameliorates inflammation by inhibiting MyD88/NF‐κB and MyD88/MAPK signaling pathways

Conclusions And ImplicationsPGG reduces the activation of NF‐κB and MAPK signaling pathways by directly influencing the MyD88 adaptor protein. PGG may ameliorate inflammatory diseases such as colitis.
Source: British Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Research Paper Source Type: research